Little Green Pharma Ltd (ASX: LGP) has entered a binding letter of intent to acquire Health House Australia Pty Ltd, a medicinal cannabis distribution business, for AU$1.25 million. The acquisition aligns with LGP's strategy of expanding through sustainable businesses at attractive valuations. Health House currently generates approximately AU$7.5 million in annual revenue and operates at a cashflow breakeven level. The acquisition is expected to deliver significant operational synergies and strengthen LGP’s vertical integration, while ensuring Health House remains a key distribution partner.
The deal includes an exclusivity period until 31 January 2025, during which LGP will complete due diligence and finalize terms. LGP has already paid a AU$50,000 non-refundable deposit and a AU$25,000 refundable deposit, both applied toward the final price. This move positions LGP to enhance its presence in the medicinal cannabis market and capitalize on strategic growth opportunities.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Mar 27, 2025
Mar 27, 2025
Mar 27, 2025
Mar 27, 2025
Mar 27, 2025
Mar 27, 2025
Mar 27, 2025
Mar 27, 2025
Mar 27, 2025
Mar 26, 2025
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.